Lipigon Pharmaceuticals AB (publ) 9RP.F Stock
Lipigon Pharmaceuticals AB (publ) Price Chart
Lipigon Pharmaceuticals AB (publ) 9RP.F Financial and Trading Overview
| Lipigon Pharmaceuticals AB (publ) stock price | 0.01 EUR |
| Previous Close | 0.03 EUR |
| Open | 0.02 EUR |
| Bid | 0.02 EUR x N/A |
| Ask | 0.03 EUR x N/A |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.01 - 0.21 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 449.44K EUR |
| Beta (5Y Monthly) | 0.857547 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9RP.F Valuation Measures
| Enterprise Value | 510.16K EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Lipigon Pharmaceuticals AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.857547 |
| 52-Week Change | -86.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.21 EUR |
| 52 Week Low | 0.01 EUR |
| 50-Day Moving Average | 0.03 EUR |
| 200-Day Moving Average | 0.07 EUR |
9RP.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 24.51M |
| Float | 18.9M |
| Short Ratio | N/A |
| % Held by Insiders | 6.30% |
| % Held by Institutions | 4.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -187.97% |
| Return on Equity (ttm) | -647.026% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -31655000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.608 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Lipigon Pharmaceuticals AB (publ)
| Country | Germany |
| State | N/A |
| City | Umeå |
| Address | TvistevAegen 48 C |
| ZIP | 90736 |
| Phone | 46 7 05 78 17 68 |
| Website | https://www.lipigon.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was incorporated in 2010 and is based in Umeå, Sweden.
Q&A For Lipigon Pharmaceuticals AB (publ) Stock
What is a current 9RP.F stock price?
Lipigon Pharmaceuticals AB (publ) 9RP.F stock price today per share is 0.01 EUR.
How to purchase Lipigon Pharmaceuticals AB (publ) stock?
You can buy 9RP.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lipigon Pharmaceuticals AB (publ)?
The stock symbol or ticker of Lipigon Pharmaceuticals AB (publ) is 9RP.F.
Which industry does the Lipigon Pharmaceuticals AB (publ) company belong to?
The Lipigon Pharmaceuticals AB (publ) industry is Biotechnology.
How many shares does Lipigon Pharmaceuticals AB (publ) have in circulation?
The max supply of Lipigon Pharmaceuticals AB (publ) shares is 227.89M.
What is Lipigon Pharmaceuticals AB (publ) Price to Earnings Ratio (PE Ratio)?
Lipigon Pharmaceuticals AB (publ) PE Ratio is now.
What was Lipigon Pharmaceuticals AB (publ) earnings per share over the trailing 12 months (TTM)?
Lipigon Pharmaceuticals AB (publ) EPS is -0.02 EUR over the trailing 12 months.
Which sector does the Lipigon Pharmaceuticals AB (publ) company belong to?
The Lipigon Pharmaceuticals AB (publ) sector is Healthcare.